{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:58:35Z","timestamp":1773093515535,"version":"3.50.1"},"reference-count":29,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background: Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) is an inborn error affecting fatty acid \u03b2-oxidation (FAO). Differently than other FAO deficiencies, LCHADD patients may develop progressive retinopathy and peripheral neuropathy. The pathogenesis of retinopathy is not completely understood, and the role of dietary interventions in preventing the development of retinopathy remains uncertain. We examined the literature to assess the impact of the dietary management of LCHADD patients on retinopathy prevention. Methods: Our systematic search included studies published in the last 20 years according to PRISMA guidelines. The aims of the review were to analyze the correlation between retinopathy and the following: (1) age at first metabolic decompensation and\/or at the start of the dietary treatment, (2) chronic dietary treatment, (3) emergency regimens, (4) other nutritional supplements. The protocol was registered in PROSPERO, and evidence was assessed using the GRADE system. Results: Seven full papers were identified according to search criteria, with only four including meaningful data. Early presentation of the disease, acute neonatal symptoms, and a suboptimal chronic treatment control were associated with more aggressive retinopathy and a poorer sight outcome. The number of metabolic decompensations and\/or hospitalizations were also positively correlated with vision loss. Chronic fat modulation in the diet had less impact than emergency treatments. The role of other nutritional supplements was not well defined. Conclusions: Newborn screening may improve retinal outcomes. Nevertheless, early treatment adopting the current LCHADD therapeutic regimen can often only delay the onset of retinopathy. Clearly, our current treatment strategies are not adequate and retina-specific treatments are needed. The optimal composition of the diet, the role of fasting limitation, and the benefits of some nutritional supplements deserve further investigations.<\/jats:p>","DOI":"10.3390\/children12030374","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T15:24:56Z","timestamp":1742225096000},"page":"374","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Focus on the Role of Dietary Treatment in the Prevention of Retinal Dysfunction in Patients with Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency: A Systematic Review"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0445-2974","authenticated-orcid":false,"given":"Evelina","family":"Maines","sequence":"first","affiliation":[{"name":"Division of Pediatrics, Santa Chiara General Hospital, APSS Trento, 38122 Trento, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3557-8078","authenticated-orcid":false,"given":"Giorgia","family":"Gugelmo","sequence":"additional","affiliation":[{"name":"Division of Metabolic Diseases, Department of Medicine, Padova University Hospital, 35128 Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5147-4367","authenticated-orcid":false,"given":"Nicola","family":"Vitturi","sequence":"additional","affiliation":[{"name":"Division of Metabolic Diseases, Department of Medicine, Padova University Hospital, 35128 Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Dianin","sequence":"additional","affiliation":[{"name":"Inherited Metabolic Diseases Unit and Regional Centre for Newborn Screening, Diagnosis and Treatment of Inherited Metabolic Diseases and Congenital Endocrine Diseases, University Hospital of Verona, 37126 Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rubert","sequence":"additional","affiliation":[{"name":"Inherited Metabolic Diseases Unit and Regional Centre for Newborn Screening, Diagnosis and Treatment of Inherited Metabolic Diseases and Congenital Endocrine Diseases, University Hospital of Verona, 37126 Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Piccoli","sequence":"additional","affiliation":[{"name":"CIBIO\u2014Department of Cellular, Computational and Integrative Biology, University of Trento, 38123 Trento, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Soffiati","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, Santa Chiara General Hospital, APSS Trento, 38122 Trento, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittoria","family":"Cauvin","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, Santa Chiara General Hospital, APSS Trento, 38122 Trento, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2230-7148","authenticated-orcid":false,"given":"Roberto","family":"Franceschi","sequence":"additional","affiliation":[{"name":"Division of Pediatrics, Santa Chiara General Hospital, APSS Trento, 38122 Trento, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"ref_1","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., and Amemiya, A. (2024, May 01). Long-Chain Hydroxyacyl-CoA Dehydrogenase Deficiency\/Trifunctional Protein Deficiency, GeneReviews(R) [Internet], Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK583531\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.37765\/ajmc.2020.88480","article-title":"Long-chain fatty acid oxidation disorders and current management strategies","volume":"26","author":"Vockley","year":"2020","journal-title":"Am. J. Manag. Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10545-010-9188-1","article-title":"Current issues regarding treatment of mitochondrial fatty acid oxidation disorders","volume":"33","author":"Spiekerkoetter","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10545-009-1126-8","article-title":"Treatment recommendations in long-chain fatty acid oxidation defects: Consensus from a workshop","volume":"32","author":"Spiekerkoetter","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1005437616934","article-title":"Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey","volume":"22","author":"Gillingham","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/apa.13313","article-title":"Earlier diagnosis and strict diets improve the survival rate and clinical course of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency","volume":"105","author":"Immonen","year":"2016","journal-title":"Acta Paediatr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2012.02.015","article-title":"Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies","volume":"106","author":"Fletcher","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/apa.13536","article-title":"Most patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency develop pathological or subnormal retinal function","volume":"105","author":"Fahnehjelm","year":"2016","journal-title":"Acta Paediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000334874","article-title":"Refined staging for chorioretinopathy in long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency","volume":"48","author":"Tyni","year":"2012","journal-title":"Ophthalmic Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/13816810.2024.2303682","article-title":"A proposal for an updated staging system for LCHADD retinopathy","volume":"45","author":"Wongchaisuwat","year":"2024","journal-title":"Ophthalmic Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1023\/A:1005502626406","article-title":"Docosahexaenoic acid and retinal function in children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency","volume":"22","author":"Harding","year":"1999","journal-title":"J. Inherit. Metabol. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"108440","DOI":"10.1016\/j.pharmthera.2023.108440","article-title":"The essential role of docosahexaenoic acid and its derivatives for retinal integrity","volume":"247","author":"Swinkels","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.brainres.2008.11.031","article-title":"Docosahexaenoic acid (DHA) has neuroprotective effects against oxidative stress in retinal ganglion cells","volume":"1251","author":"Shimazawa","year":"2009","journal-title":"Brain Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2023.05.010","article-title":"The development methods of official GRADE articles and requirements for claiming the use of GRADE\u2014A statement by the GRADE guidance group","volume":"159","author":"Brennan","year":"2023","journal-title":"J. Clin. Epidemiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13023-015-0236-7","article-title":"Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with Long-Chain 3-Hydroxy Acyl CoA Dehydrogenase Deficiency (LCHADD)","volume":"10","author":"Karall","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymgme.2005.06.001","article-title":"Effect of optimal dietary therapy upon visual function in children with longchain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency","volume":"86","author":"Gillingham","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"ref_18","first-page":"329","article-title":"Ocular characteristics in 10 children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: A cross-sectional study with long-term follow-up","volume":"86","author":"Fahnehjelm","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/jimd.12738","article-title":"Early diagnosis and treatment by newborn screening (NBS) or family history is associated with improved visual outcomes for long-chain 3-hydroxyacylCoA dehydrogenase deficiency (LCHADD) chorioretinopathy","volume":"47","author":"Gillingham","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/13816810.2020.1836658","article-title":"Retained visual function in a subset of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD)","volume":"42","author":"Dulz","year":"2021","journal-title":"Ophthalmic Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1167\/iovs.65.6.33","article-title":"The LCHADD Mouse Model Recapitulates Early-Stage Chorioretinopathy in LCHADD Patients","volume":"65","author":"Babcock","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Gaston, G., Babcock, S., Ryals, R., Elizondo, G., DeVine, T., Wafai, D., Packwood, W., Holden, S., Raber, J., and Lindner, J.R. (2023). A G1528C Hadha knock-in mouse model recapitulates aspects of human clinical phenotypes for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Commun. Biol., 6.","DOI":"10.1038\/s42003-023-05268-1"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/iovs.65.11.22","article-title":"iPSC-Derived LCHADD Retinal Pigment Epithelial Cells Are Susceptible to Lipid Peroxidation and Rescued by Transfection of a Wildtype AAV-HADHA Vector","volume":"65","author":"DeVine","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Tucci, S. (2022). An Altered Sphingolipid Profile as a Risk Factor for Progressive Neurodegeneration in Long-Chain 3-Hydroxyacyl-CoA Deficiency (LCHADD). Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137144"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1167\/iovs.14-14007","article-title":"Patient-specific induced pluripotent stem cell-derived RPE cells: Understanding the pathogenesis of retinopathy in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency","volume":"56","author":"Polinati","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00018-016-2147-8","article-title":"Kaarniranta. Inflammation and its role in age-related macular degeneration","volume":"73","author":"Kauppinen","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1096-7192(03)00073-8","article-title":"Optimal dietary therapy of long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency","volume":"79","author":"Gillingham","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"ref_28","first-page":"80","article-title":"Metabolomics, acylcarnitines, genotype, visual acuity and diet among 39 patients with LCHADD\/TFPD","volume":"47","author":"Gillingham","year":"2024","journal-title":"Abstracts. J. Inherit. Metab. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e2021053924","DOI":"10.1542\/peds.2021-053924","article-title":"Retinopathy of Prematurity: A Global Perspective and Recent Developments","volume":"150","author":"Sabri","year":"2022","journal-title":"Pediatrics"}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/12\/3\/374\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:55:15Z","timestamp":1760028915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/12\/3\/374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["children12030374"],"URL":"https:\/\/doi.org\/10.3390\/children12030374","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]}}}